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further careful investigation. For example,
although the authors found that Ang1
increased the proportion of quiescent
MyoD cells in differentiating myogenic
cultures, this effect was most marked
when the stimulus was added at later
time points. In contrast, asymmetric mi-
toses that produce both MyoD+ and
MyoD daughters have been observed
mainly during the initial cell divisions of
satellite cell cultures (Zammit et al., 2004;
Kuang et al., 2008). It may be that the
Ang1/Tie2-induced entry into quiescence
is operating on cells in which the decision
to stay in the stem cell pool has already
been made during the earlier asymmetric
division. Another possibility is that Ang1
induces the MyoD quiescent state in
both preordained stem cells and cells that
are on the path to terminal differentiation.
The demonstration that nonmyogenic
cells regulate myogenic cells via shared
mechanisms raises the possibility of reci-
procity between the myogenic and non-
myogenic populations. Our practical in-
terest in the mechanisms of repair of
skeletal muscle is largely powered by the
desire to mitigate the suboptimal outcome
seen in chronic conditions of muscle
degenerationand repair, as in themuscular
dystrophies. Derangement of the web of
mechanismsdescribed in this article surely
plays some central role in the progressive
failure of regeneration and loss of normal
muscle structure and function that occur
in these chronic conditions. It has been
suggested, for example, that the progres-
sive fibrosis that characterizes severe
dystrophies is inimical tomuscle regenera-
tion. This inhibition is commonly attributed
to straightforward physical obstruction,
but the observation that Ang1 secreted
by fibroblasts can induce satellite cell
quiescence identifies this population, and
the pathway, as candidates for targeted
therapeutic strategies. One might also
ponder whether factors from the satellite
cells impinge reciprocally on the behavior
of their smooth muscle, fibroblast, and
endothelial neighbors, not to mention their
previously identified interactions with
patrolling cells of the monocyte macro-
phage series (Chazaud et al., 2003).
Plainly, effective function of a stem cell
requires exquisite attunement to its envi-
ronment, particularly when, as in the
case of the skeletal muscle satellite cell,
it is obliged to spend most of its time
soundly asleep while remaining respon-
sive to sporadic ‘‘rude awakenings’’
evoked by muscle damage. We should
not be surprised, therefore, at the subtlety
and complexity of intercellular and autolo-
gous signaling activity that is being
revealed by the investigations of the Cha-
zaud group in consequence of an inclu-
sive approach that goes beyond simply
examining the actions of stem cells in
isolation and that embraces the multifar-
ious influences of the cellular community.
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Stress can activate tumor-suppressive mechanisms, causing the loss of adult stem cell function with age. In
this issue of Cell Stem Cell and in Nature, Castilho et al. (2009) and Harrison et al. (2009) highlight the impor-
tance of mTOR signaling in stem cell exhaustion and mammalian aging, respectively.The process of aging is characterized by
the reduced capacity to maintain tissue
homeostasis and repair damaged tissues
after injury. Physiological aging appears232 Cell Stem Cell 5, September 4, 2009 ª2to be due, in part, to a decline in the
regenerative capacity of adult tissue
stem cells. Loss of stem cell function
with age can result from cell-intrinsic009 Elsevier Inc.changes as well as environmental factors.
For example, the accumulation of DNA
damage in melanocyte stem cells (MSCs)
triggers their differentiation, leading to the
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Previewsdepletion of the MSC pool
and the graying of hair (Ino-
mata et al., 2009). Similarly,
the accumulation of DNA
damage as well as potential
epigenetic changes in hema-
topoietic stem cells (HSCs)
reduce their function with
age, a reduction that is
related not only to changes
in HSC number but also to
changes in their mobilization,
homing, and differentiation
(Rossi et al., 2008). Finally,
the aging of satellite cells of
muscle can be reversed by
exposure to a young blood
supply, suggesting that cell-
extrinsic, microenvironmental
factors may also play a role
in the impaired function of
certain stem cell populations
with age (Conboy et al.,
2005).
Recent evidence suggests
that stress resulting from
DNAdamage,oxidativestress,
telomerase dysfunction, or
persistent growth signaling
can lead to the loss of stem
cell function by activating
tumor-suppressive mechanisms that
lead to senescence (Rossi et al., 2008). It
is known that stem cells from multiple
tissues express senescence markers
with age. Further, studies addressing the
functional role of tumor-suppressive
mechanisms in aging demonstrated in
HSCs, neural stem cells (NSCs), and
pancreatic islet stem cells that not only
do levels of p16INK4a (a known mediator
of senescence) increase with age but
also that deficiency of this tumor sup-
pressor partially attenuated the age-
induced replicative failure of these tissues
(Janzen et al., 2006; Krishnamurthy et al.,
2006; Molofsky et al., 2006). Addressing
the role of oncogenic growth signaling in
stem cell function, Yilmaz and colleagues
demonstrated that deletion of Pten, which
negatively regulates proliferation and
survival through the phosphatidylinositol-
3-OH kinase [PI(3)K] pathway, led to the
short-term expansion of HSCs followed
by their depletion. Most of these effects
were dependent on downstream signaling
through the mammalian target of rapamy-
cin (mTOR), given that pharmacological
inhibition of mTOR with rapamycin pre-
vented the phenotypic reduction in
HSCs and rescued most of their in vivo
functions (Yilmaz et al., 2006). Although
the mechanisms responsible for stem
cell depletion observed in the above
examples were not conclusively eluci-
dated, and may have involved senes-
cence as well as altered self-renewal or
differentiation, these studies nevertheless
suggest a general theme wherein tumor-
suppressive mechanisms play an impor-
tant role in regulating stem cell function
with age.
In this issue of Cell Stem Cell, Castilho
and colleagues expand on this theme
by demonstrating that persistent growth
signaling (mediated by Wnt1 overexpres-
sion) in hair follicles (HFs) causes aggres-
sive HF growth followed by epithelial cell
senescence, loss of the epidermal stem
cell compartment, and progressive hair
loss (Castilho et al., 2009). Interestingly,
although Wnt1 expression led to activa-
tion of both b-catenin and the mTOR
pathway, hair-follicle hyperproliferation
and stem cell loss could be largely
reversed with rapamycin, suggesting that
mTOR plays a dominant role in this
process (Figure 1). This work
extends the principle that sus-
tained mTOR signaling can
lead to the loss of stem cell
function to a tissue outside of
the hematopoietic system.
Further, although the authors
cannot conclusively rule out
the role of other processes in
contributing to the observed
loss of hair-follicle stem cells,
their results suggest that se-
nescence plays a prominent
role as a protective mecha-
nism to prevent tumor forma-
tion in the face of persistent
mTOR activation.
Together, this body of work
suggests a delicate balance
between the process of aging,
which is mediated in part
through tumor-suppressive
mechanisms that lead to the
loss of stem cell function,
and cancer, which occurs in
the absence of such tumor-
suppressive mechanisms.
Moreover, it also suggests
a particularly important role
for the mTOR pathway in
aging and stem cell exhaus-
tion. This begs the question of whether
the blockade of senescence-inducing
signals such as those produced by persis-
tent mTOR activation can lead not only to
the preservation of individual tissue stem
cell populations but also to the slowing of
organismal aging. This hypothesis is
bolstered by previous observations that
TOR inhibition can lead to lifespan exten-
sion in invertebrates including yeast,
nematodes, and fruit flies (Schieke and
Finkel, 2006). Addressing this question
for the first time in mammals, a recent
study in Nature found that rapamycin,
when fed to mice beginning at 600 days
of age, extends median and maximal life-
span in both males and females (Harrison
et al., 2009). On the basis of age at 90%
mortality, rapamycin led to a 14%
increase in female lifespan and a 9%
increase in males. Similarly, when rapa-
mycin treatment began at 270 days,
increased survival was also observed
in both genders. These highly significant
findings reveal a role for mTOR signaling
in the regulation of mammalian lifespan
as well as demonstrate pharmacological
lifespan extension in both genders.
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Figure 1. Simplified Schematic Depicting Hair-Follicle Stem Cell
Exhaustion Mediated by Wnt1 Overexpression
Overexpression of Wnt1 causes rapid hair-follicle hyperproliferation (not
shown) followed by the loss of CD34+ hair-follicle stem cells (blue) and the
appearance of nuclear phosphorylated gH2AX foci (red) indicative of DNA
double-strand breaks, a marker of senescence. Wnt1 overexpression also
promotes the expression of endogenous b-galactosidase at pH 6, another
characteristic of senescent cells, and progressive hair loss. Hair-follicle hyper-
proliferation, the loss of CD34+ hair-follicle stem cells, and the appearance of
senescence markers can be largely reversed by pharmacological inhibition of
mTORC1 with rapamycin.Cell Stem Cell 5, September 4, 2009 ª2009 Elsevier Inc. 233
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new questions. For example, was the
observed lifespan extension in mice
caused by delaying deaths from cancer,
delaying the mechanisms of aging, or
both? Does mTOR inhibition decrease
stem cell senescence or increase the
function of various tissue stem cell popu-
lations in comparison with age-matched
controls? Perhaps most importantly,
what are the molecular mechanisms con-
necting mTOR and aging? Potential clues
to this question come from our under-
standing of mTOR biology. The mTOR
kinase nucleates two distinct signaling
complexes, mTORC1 and mTORC2, one
of which (mTORC1) is allosterically in-
hibited by rapamycin. The activation of
mTORC1 in response to a broad range of
progrowth signals is known to regulate
mitochondrial activity, which itself has
been shown in several studies to be
involved in the regulation of lifespan.Mito-
chondria may exert this influence throughLineage Commitm
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Instructive and permissive models
recent issues of Science and Cell, R
can instruct lineage choice.
Multipotent hematopoietic stem cells
(HSCs) with the ability to reconstitute the
blood and lymphoid lineages long term
and to self-renew are predominantly
quiescent, dividing only in response to
demand for blood cells (Wilson et al.,
2008). Both multilineage and lineage-
specific cytokines synergistically regulate
the proliferation and differentiation of
these long term (LT)-HSCs that express
receptors for several of the lineage-
specific cytokines. A major area of
conjecture in the HSC field has been
whether cytokines can ‘‘instruct’’ lineage
commitment (Metcalf, 1998) or whether
their actions are simply ‘‘permissive’’
234 Cell Stem Cell 5, September 4, 2009 ª2the generation of intracellular reactive
oxygen species (ROS) (Schieke and Fin-
kel, 2006), which, in previous work, have
been suggested to contribute to HSC
exhaustion (Tothova et al., 2007). The
connection between mTOR and ROS
production is far from understood at the
molecular level, but these typesof findings
point to a potential direction for future
research into the role of mTOR signaling
in aging and stem cell function.
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(Enver et al., 1998), allowing the survival
and expansion of already committed
cells. Although both cell-autonomous
transcription factors (Laiosa et al., 2006)
and the activation of ectopically ex-
pressed cytokine receptors (Kondo et al.,
2000) have been shown to instruct lineage
choice, it has been technically difficult to
demonstrate an instructive action of cyto-
kines in nonengineered cells. Two recent
papers that used novel approaches
(Rieger et al., 2009; Sarrazin et al., 2009)
convincingly demonstrate that cytokines
can instruct.
Macrophage CSF (M-CSF), also known
as colony stimulating factor-1 (CSF-1)
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d for hematopoietic cytokines. In
2009) together show that cytokines
and granulocyte CSF (G-CSF), generate
clones from cultured hematopoietic cells
that are composed almost exclusively
of macrophages (Ms) or granulocytes
(Gs), respectively. Using novel bioimaging
approaches that permit continuous long-
term observation at the single-cell level
(Eilken et al., 2009), Rieger et al. (2009)
used time-lapse movies of cultures of
purified bipotent granulocyte/monocyte
progenitors (GMPs) to follow the fate of
unselected progenitors as they differen-
tiate to either Ms or Gs. GMPs, which do
not express lysozyme, were obtained
from Lys::GFP mice in which enhanced
green fluorescent protein expression is
